Health related quality of life in older patients with solid tumors and prognostic factors for decline.


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
11 2019
Historique:
received: 01 10 2018
revised: 18 01 2019
accepted: 25 03 2019
pubmed: 22 4 2019
medline: 17 9 2020
entrez: 22 4 2019
Statut: ppublish

Résumé

This study aims to investigate health-related quality of life (HRQOL) at baseline and at follow-up in older patients with cancer and to determine prognostic factors for HRQOL decline. A prospective Belgian multicentre (n = 22) study was performed. Patients ≥70 years with a malignant tumor and abnormal G8 (≤14/17) screening tool were included. Patients underwent geriatric assessment (GA) and HRQOL evaluation with follow up at three months. Uni- and multivariate regression models were performed to determine factors associated (p < .05) with baseline HRQOL and HRQOL decline at follow-up. Results reflect data collected from 3673 patients. A multivariate analysis showed that younger patients, and those with poor Eastern Cooperative Oncology Group - Performance Status (ECOG-PS), specific tumor types (gastrointestinal, gynaecological and thorax) and higher stage had lower baseline HRQOL. In addition worse functional status and presence of pain, fatigue, depression and malnutrition were associated with lower baseline HRQOL. During treatment (n = 2972), improvement in HRQOL was observed in 1037 patients (35%) and a decline in 838 patients (28.2%). In multivariate analysis, stage and presence of baseline comorbidities, pain, fatigue or malnutrition were associated with HRQOL evolution. Baseline HRQOL in older patients with cancer and an abnormal G8 depends on tumor and age related parameters. During follow-up, HRQOL improved in one third of patients, indicating that they may benefit from cancer treatment while one quarter demonstrated a HRQOL decline for which prognostic factors were identified.

Identifiants

pubmed: 31005649
pii: S1879-4068(18)30373-4
doi: 10.1016/j.jgo.2019.03.018
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

895-903

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Lore Decoster (L)

Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: lore.decoster@uzbrussel.be.

Chantal Quinten (C)

Laboratory of Experimental Oncology (LEO), Department of Oncology, KU, Leuven, Belgium.

Cindy Kenis (C)

Department of General Medical Oncology and Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.

Johan Flamaing (J)

Department of Geriatric Medicine, University Hospitals Leuven and Department of Chronic Diseases, Metabolism and Ageing - CHROMETA, KU Leuven, Leuven, Belgium.

Philip R Debruyne (PR)

Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, UK.

Inge De Groof (I)

Department of Geriatric Medicine, Iridium Cancer Network Antwerp, St. Augustinus, Wilrijk, Belgium.

Christian Focan (C)

Department of Oncology, Clinique Saint-Joseph, CHC-Liège Hospital Group, Liège, Belgium.

Frank Cornelis (F)

Department of Medical Oncology, Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium.

Vincent Verschaeve (V)

Department of Medical Oncology, GHDC Grand Hôpital de Charleroi, Charleroi, Belgium.

Christian Bachmann (C)

Department of Geriatric Medicine, AZ Sint-Lucas, Gent, Belgium.

Dominique Bron (D)

Department of Hematology, ULB Institut Jules Bordet, Brussels, Belgium.

Sylvie Luce (S)

Department Medical Oncology, University Hospital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Gwenaëlle Debugne (G)

Department of Geriatric Medicine, Centre Hospitalier de Mouscron, Mouscron, Belgium.
Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium.

Jean-Charles Goeminne (JC)

Department of Medical Oncology, CHU-UCL-Namur, Site Sainte-Elisabeth, Namur, Belgium.

Abdelbari Baitar (A)

Department of Medical Oncology, ZNA Middelheim, Antwerp, Belgium.

Katrien Geboers (K)

Centre for Oncology and Hematology, AZ Turnhout, Turnhout, Belgium.

Benedicte Petit (B)

Department of Medical Oncology, Centre Hospitalier Jolimont, La Louvière, Belgium.

Christine Langenaeken (C)

Department Medical Oncology, Iridium Cancer Network Antwerp, AZ Klina, Brasschaat, Belgium.

Ruud Van Rijswijk (R)

Department Medical Oncology, ZNA Stuivenberg, Antwerp, Belgium.

Pol Specenier (P)

Department of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium.

Guy Jerusalem (G)

Department of Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liege University, Liege, Belgium.

Jean-Philippe Praet (JP)

Department of Geriatric Medicine, CHU St-Pierre, Free Universities Brussels, Brussels, Belgium.

Katherine Vandenborre (K)

Department of Medical Oncology, AZ Vesalius, Tongeren, Belgium.

Jean-Pierre Lobelle (JP)

Consultant in Statistics, Beernem, Belgium.

Michelle Lycke (M)

Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, UK.

Koen Milisen (K)

Department of Geriatric Medicine, University Hospitals Leuven, Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium.

Hans Wildiers (H)

Department of General Medical Oncology, University Hospitals Leuven, Department of Oncology, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH